BSE filing, NSE: NATCOPHARM. Summary written from the filing by ALFA Finder's alert engine.
Natco Pharma Ltd: key numbers
- Share price
- ₹782.40
- Market cap
- ₹15,348 Cr
- Revenue (annual)
- ₹4,078 Cr
- Net profit (annual)
- ₹1,418 Cr
- P/E (TTM)
- 13.4×Sector 45.9×
- Promoter holding
- 49.39%-0.03% QoQ
- FII holding
- 15.99%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Natco Pharma Ltd
All →Natco Pharma Capital Structure Change
Natco Pharma allotted 5,86,666 equity shares to promoter Venkaiah Chowdary Nannapaneni via its rights issue, valued at ~₹44 Crore. This lifts his stake to 14.60%.
- Value
- ₹44.00 Cr
Natco Pharma Employee Stock Options
Natco Pharma's insiders, including promoters and directors, were allotted equity shares. This allotment increases their total shareholding in the company.
- Value
- ₹144.2 Cr
Natco Pharma Board Meeting Date
Natco Pharma will hold a board meeting on 13 November 2026 to consider unaudited quarterly results and an interim dividend. Trading window closed until 15 November 2026.
Natco Pharma Capital Structure Change
Natco Pharma's ₹1,279.4 Crore rights issue closed on October 22, 2026. Shares were priced at ₹750 each on a ₹2 face value.
- Value
- ₹1,279 Cr
Natco Pharma Product Launch
Natco Pharma launches Carboplatin Injection, a Paraplatin® generic, in the U.S. market via its subsidiary. The oncology product addresses a critical U.S. supply shortage.
Natco Pharma Other Announcement
Natco Pharma Ltd has submitted its quarterly shareholding pattern for the period ended September 30, 2026. This filing is a routine regulatory compliance submission.
Other other announcement announcements
All →Robokidz Eduventures Other Announcement
Robokidz Eduventures filed its quarterly shareholding pattern for the period ended 30 September 2026. This is routine SEBI Regulation 31 disclosure with no transaction or corporate event.
Innomet Advanced Materials Other Announcement
Innomet Advanced Materials filed its half-year Reg 32 statement on preferential issue proceeds, with no deviation. Rs.753.25 lakh raised in August 2026 was fully used for working capital.
CCME Global Other Announcement
CCME Global disclosed insider trades by two connected persons, acquiring 90 lakh and 22.5 lakh shares on 28 October 2026. Combined consideration is stated as Rs.112.50 Crore.
- Value
- ₹112.5 Cr
Jay Jalaram Technologies Other Announcement
Jay Jalaram Technologies named its KMP as authorised persons for materiality determination under Regulation 30. This administrative listing carries no financial or business impact.
SPR Auto Technologies Other Announcement
SPR Auto Technologies filed its quarterly QIP monitoring agency report for the quarter ended September 30, 2026. The report found no deviation from the issue objects.
Vahh Chemicals Other Announcement
Vahh Chemicals filed its shareholding pattern for the quarter ended September 30, 2026. Promoters and promoter group hold about 64.63% of total shares.